Pharmafile Logo
Pharmafocus logo
Advanced Search

Daiichi Sankyo

Showing 14 posts of 59 posts found.

Daiichi Sankyo chief executive elected NPC chairman of the Board

November 19, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo

The National Pharmaceutical Council (NPC) has announced that Daiichi Sankyo president and chief executive John Gargiulo has been elected chairman …

Appointment
Daiichi Sankyo UK

Daiichi Sankyo: breaking down barriers with social media

August 1, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chatter, Daiichi Sankyo, NHS, social media

Digital media is known to help create interaction and dialogue between groups and organisations, but new technology can also create …

Feature

New chief executive for Daiichi Sankyo Europe

July 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daiichi Sankyo

Jan Van Ruymbeke has been appointed as the new chief executive of Daiichi Sankyo Europe from October. Van Ruymbeke, from Belgium, …

Appointment
Yammer image

Microsoft buys Yammer for $1.2 billion

June 28, 2012
Medical Communications Daiichi Sankyo, Facebook, Microsoft, Yammer, social network

Microsoft has acquired Yammer, an internal social networking system for businesses, for $1.2 billion. Set up in 2008, Yammer closely …

News

Daiichi Sankyo subsidiary gets FDA warning

September 15, 2011
Daiichi Sankyo, FDA, Luitpold

Daiichi Sankyo’s US subsidiary Luitpold Pharmaceuticals has been sent a warning letter by the FDA for “significant” and repeated quality …

News

Daiichi Sankyo: Europe poses huge challenge for pharma

June 9, 2011
Research and Development, Sales and Marketing Cancer, Daiichi Sankyo, pricing

Japanese pharma company Daiichi Sankyo is expanding its European operations, creating a new oncology business unit. But outlining its plans …

News
Japanese rescue workers

Japan’s pharma industry pledges to maintain medicines supply

March 17, 2011
Sales and Marketing Astellas, Boehringer Ingelheim, Daiichi Sankyo, Eisai, Japan, earthquake

Pharmaceutical firms in Japan have escaped the very worst of the devastation caused by the earthquake and tsunami, and have …

News

Daiichi recalls contaminated paediatric vaccines

March 15, 2011
Manufacturing and Production ActHIB, Daiichi Sankyo, manufacturing compliance, padiatric vaccine recall, recalls, vaccines

Japanese drugmaker Daiichi Sankyo has recalled around 1.3 million doses of the paediatric vaccine ActHIB, manufactured by Sanofi-Aventis, because of …

News

Daiichi Sankyo gains rights to potential blockbuster cancer drug

March 2, 2011
Research and Development BRAF protein, Daiichi Sankyo, PLX4032, Plexxikon, melanoma, personalised medicine

Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …

News

Daiichi-Sankyo cleared of rep misconduct

November 22, 2010
Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Daiichi Sankyo, Daiichi-Sankyo, Olmetec, PMCPA, olmesartan, pharma sales representative

Daiichi-Sankyo has been cleared of any wrongdoing in relation to the ABPI Code after one of its representatives was accused …

News
ArunSawhneyWebV

Ranbaxy chief executive steps down

August 13, 2010
Medical Communications, Sales and Marketing Daiichi Sankyo, Ranbaxy

The chief executive of Ranbaxy Mr Atul Sobti is to step down after an apparent a rift with the company’s …

News

Abbott and Daiichi Sankyo acclaimed in great places to work survey

May 31, 2010
Business Services Abbott, Daiichi Sankyo

The Great Place to Work Institute has named Abbott as one of the Top 50 Best Workplaces in the UK, …

News

Dr Jay Feingold joins Daiichi Sankyo

February 19, 2010
Research and Development Daiichi Sankyo, appointment, research and development

Daiichi Sankyo’s US arm has appointed Dr Jay Feingold vice president of medical affairs. In this role his will manage …

Appointment

Effient approved in US

July 17, 2009
Research and Development, Sales and Marketing Daiichi Sankyo, Effient, US, lilly

Lilly and Daaichi-Sankyo have gained US approval of their new blood clotting treatment Effient, but hopes of strong sales are …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025